Compare EML & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | CVRX |
|---|---|---|
| Founded | 1858 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9M | 139.8M |
| IPO Year | 1995 | 2021 |
| Metric | EML | CVRX |
|---|---|---|
| Price | $25.55 | $3.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 9.0K | ★ 1.4M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 185.40 | 23.02 |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $248,970,345.00 | $56,651,000.00 |
| Revenue This Year | $19.05 | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | $24.63 | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $17.61 | $2.20 |
| 52 Week High | $29.91 | $11.30 |
| Indicator | EML | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.90 |
| Support Level | N/A | $2.20 |
| Resistance Level | N/A | $3.24 |
| Average True Range (ATR) | 0.00 | 0.30 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 26.32 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.